Saturday, March 2, 2024


Home Tags Lifespan Inc.

Tag: Lifespan Inc.

Lifespan participating in Phase 3 clinical trial of Novavax vaccine

PROVIDENCE – Lifespan Corp. began vaccinating volunteer participants this week as one of 110 host sites in the Phase 3 clinical trial for the...
MAKING INTRODUCTIONS: Monica Anderson, Lifespan director of community relations and corporate citizenship, speaks to people attending a Rhode Island Hospital community job fair in October. / PBN PHOTO/RUPERT WHITELEY

Lifespan’s mentoring program part of a different kind of care

2019 PBN Business Excellence Awards EXCELLENCE IN COMMUNITY INVOLVEMENT: Lifespan Corp. Lifespan corp. came into existence in 1994, when it was founded by Rhode Island...

Budget plan rankles tax-exempts

Nonprofit hospitals and universities have long made voluntary payments to local communities that recognize the cost of emergency services provided by the hosts. These same...
SEASONED INTERPRETER: Jose Cruz, left, is a medically certified interpreter who has worked for Pinpoint Translation Services in Providence for more than a decade. Cruz speaks with Elba Morales, right, of Providence, a Spanish-speaking resident of PACE Organization of Rhode Island, as Dr. Tsewang Gyurmey looks on. / PBN PHOTO/MICHAEL SALERNO

Pinpoint fills need for interpreters

As Rhode Island’s population becomes more diverse, business and government entities are encountering more people who need goods and services but who have trouble...
STEWARD HEALTHCARE's 2013 lawsuit against Blue Cross & Blue Shield of Rhode Island, alleging a conspiracy with Thundermist Health Center and Lifespan to prevent the Massachusetts hospital system from entering the Rhode Island market by buying Landmark Medical Center, is going to trial. /PBN FILE PHOTO/DAVID LEVESQUE

Steward suit alleging BCBSRI conspiracy to block Landmark sale proceeding

PROVIDENCE — Steward Healthcare’s 2013 lawsuit against Blue Cross Blue & Shield of Rhode Island alleging a conspiracy with Thundermist Health Center and Lifespan...
IMMUNOLOGY ENGINEERING BIOTECH firm EpiVax will use Small Business Innovation Research funding to develop a Tregitrope-biotherapeutic intended to restore immunological balance in Graves’ disease patients.

New EpiVax innovation could target Graves’ disease

PROVIDENCE — The first target of immunology engineering biotech firm EpiVax Inc.’s latest antigen-specific therapies? Graves’ disease, an auto-immune condition that results in hypothyroidism. Current...
- Featured Event -

Latest News